Becton Dickinson & Co (XSWX:BDX)
CHF 122.81 (0%) Market Cap: 34.09 Bil Enterprise Value: 47.42 Bil PE Ratio: 38.71 PB Ratio: 1.75 GF Score: 76/100

Becton Dickinson and Co at Barclays Global Healthcare Conference Transcript

Mar 10, 2026 / 12:30PM GMT
Release Date Price: CHF128.78
Matt Miksic
Barclays Services Corp - Analyst

Good morning. Thanks very much for joining us. I'm very pleased today to have with us Tom Polen from Becton Dickinson. Thanks so much. My name is Matt Miksic. I cover medical devices here at Barclays.

Questions & Answers

Matt Miksic
Barclays Services Corp - Analyst

So the first question is probably has to be, I guess, what's happened in the last week or so, implications for oil exposure to the Middle East. So maybe if you could, sort of step into those two issues folks are trying to get their arms around what all this might mean to Becton.

Tom Polen
Becton, Dickinson and Company - Chairman, Chief Executive Officer and President

For us we really see no impact for this year. I think of the days of oil and resins being closely tied, that's not the same. The other thing is since we've been implementing BD Excellence, and if you remember we've put in some hedging strategies around currency, we also put in much more aggressive hedging strategies around oil or resin

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot